Chief Compliance Officer, General Counsel, Company Secretary
Chief Compliance Officer, General Counsel, Company Secretary
18.38K
--
Dr. Javier San Martin, M.D.
Dr. Javier San Martin, M.D.
Chief Medical Officer
Chief Medical Officer
15.89K
--
Mr. Robert Renninger
Mr. Robert Renninger
Senior Vice President - Finance, Accounting
Senior Vice President - Finance, Accounting
15.85K
+18.89%
Ms. Kelly A. Romano
Ms. Kelly A. Romano
Independent Chairwoman of the Board
Independent Chairwoman of the Board
8.07K
--
Mr. Grant E. Pickering
Mr. Grant E. Pickering
Independent Director
Independent Director
2.58K
--
James A. Johnson ,
James A. Johnson ,
Independent Director
Independent Director
500.00
--
Ms. Barbara Kosacz, J.D.
Ms. Barbara Kosacz, J.D.
Independent Director
Independent Director
--
--
Mr. Joseph (Joe) Edelman
Mr. Joseph (Joe) Edelman
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Mark James Litton, Ph.D.
Dr. Mark James Litton, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
59.89K
--
Dr. Kevin Church, Ph.D.
Dr. Kevin Church, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
25.18K
+17.86%
Mr. Mark Worthington
Mr. Mark Worthington
Chief Compliance Officer, General Counsel, Company Secretary
Chief Compliance Officer, General Counsel, Company Secretary
18.38K
--
Dr. Javier San Martin, M.D.
Dr. Javier San Martin, M.D.
Chief Medical Officer
Chief Medical Officer
15.89K
--
Mr. Robert Renninger
Mr. Robert Renninger
Senior Vice President - Finance, Accounting
Senior Vice President - Finance, Accounting
15.85K
+18.89%
Ms. Kelly A. Romano
Ms. Kelly A. Romano
Independent Chairwoman of the Board
Independent Chairwoman of the Board
8.07K
--
Perguntas frequentes
Quem são os cinco principais acionistas de LeonaBio Ord Shs?
Os cinco principais acionistas de LeonaBio Ord Shs são: Dr. Mark James Litton, Ph.D.
Quantas instituições possuem ações da LeonaBio Ord Shs (LONA)?
Em 2026Q1, 120 instituições possuíam ações da LeonaBio Ord Shs, com valor de mercado aproximado de 6.66M, representando 70.97% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 2319889.00.